Hasegawa Hideki, Ichinohe Takeshi, Tamura Shin-ichi, Kurata Takeshi
Department of Pathology, National Institute of Infectious Diseases, Gakuen, Musashimurayama-shi, Tokyo, Japan.
Expert Rev Vaccines. 2007 Apr;6(2):193-201. doi: 10.1586/14760584.6.2.193.
Highly pathogenic avian H5N1 influenza A virus has caused influenza outbreaks in poultry and migratory birds in Southeast Asia, Africa and Europe, and there is concern that it could cause a new pandemic. This fear of an emerging pandemic of a new influenza strain underscores the urgency of preparing effective vaccines to meet the pandemic. One way to mitigate current concerns is to develop an influenza vaccine that is fully functional against drift influenza viruses. In our current situation, in which we cannot predict which strain will cause a pandemic, cross-protective immunity using potential and novel mucosal vaccines plays a particularly important role in preventing the spread of highly pathogenic influenza virus.
高致病性甲型H5N1禽流感病毒已在东南亚、非洲和欧洲的家禽及候鸟中引发流感疫情,人们担心它可能引发新一轮大流行。对新流感毒株出现大流行的这种担忧凸显了制备有效疫苗以应对大流行的紧迫性。减轻当前担忧的一种方法是研发一种对流感病毒变异株具有完全功能的流感疫苗。在我们目前无法预测哪种毒株会引发大流行的情况下,使用潜在的新型黏膜疫苗产生的交叉保护性免疫在预防高致病性流感病毒传播方面发挥着尤为重要的作用。